Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Eveline L. Tierney"'
Autor:
Elissa Malkin, Jun Gu, Qian Shen, Eveline L. Tierney, Xin Kang, Birgitte Giersing, Filip Dubovsky, Thomas C. Chen, Jinhong Hu, Qiang Wang, Carole A. Long, Jian Liu, Zhen Li, Xuegong Pan, Zhihui Chen, Yu Xu, Kathryn Tucker, Zarifah Reed, Weiqing Pan, Zhifang Cao, Xinling Bi
Publikováno v:
Vaccine. 26:6864-6873
Apical Membrane Antigen 1 (AMA1) and Merozoite Surface Protein 1 (MSP1) were produced as a recombinant fusion protein and formulated with the adjuvant Montanide ISA 720 with the aim of replicating the structure present in the parasite protein. A prev
Publikováno v:
Journal of Chronic Fatigue Syndrome. 3:69-95
“The chronic fatigue syndrome (CFS) is a clinically defined condition characterized by severe disabling fatigue and a combination of symptoms that prominently features self-reported impairments in concentration and short-term memory, sleep disturba
Publikováno v:
Virus Research. 30:43-52
Two cold-passaged mutant vaccine viruses (cp12 and cp45) derived from the JS wild-type (wt) strain of human parainfluenza virus type 3 (PIV3) have been sequenced. These mutant viruses display the cold-adapted (ca), temperature-sensitive (ts), and att
Publikováno v:
Journal of Infectious Diseases. 167:958-962
A live attenuated cold-adapted parainfluenza virus type 3 (PIV-3) vaccine is being developed to prevent the serious lower respiratory tract disease caused by this virus in infants and young children. This cold-passaged mutant (cp45) was evaluated in
Publikováno v:
Virus Research. 25:91-103
The nucleotide sequence of the JS strain of human parainfluenza virus type 3 (PIV3) was determined from a series of 14 overlapping cDNA clones and was compared to that of the previously sequenced prototype PIV3 strain, Wash/47885/57 (Galinski, 1991).
Autor:
Daming Zhu, Eveline L. Tierney, Elissa Malkin, Louis H. Miller, Kazutoyo Miura, Joanne Marjason, Suzanne L. Elliott, Laura B. Martin, Kelly M. Rausch, Gregory E. D. Mullen, Carole A. Long, Mark Pierce, Ruth D. Ellis, Michael P. Fay
Publikováno v:
Vaccine. 28(10)
A Phase 1 trial was conducted in malaria-naïve adults to evaluate the recombinant protein vaccine apical membrane antigen 1-Combination 1 (AMA1-C1) formulated in Montanide ISA 720 (SEPPIC, France), a water-in-oil adjuvant. Vaccinations were halted e
Autor:
Stephen Todryk, Filip Dubovsky, Fiona M. Thompson, Eveline L. Tierney, Ian D. Poulton, Laura Andrews, Tamara Berthoud, Anne C. Moore, Robert E. Sinden, Simon Correa, Michael Walther, Sheila M. Keating, Geoffrey Butcher, Jack Williams, Adrian V. S. Hill, Sarah C. Gilbert, Rikke Fredslund Andersen, Susanna Dunachie, Angela Hunt-Cooke
Publikováno v:
Europe PubMed Central
Heterologous prime-boost immunization with DNA and various recombinant poxviruses encoding malaria antigens is capable of inducing strong cell-mediated immune responses and partial protection in human sporozoite challenges. Here we report a series of
Autor:
Susanna Dunachie, Robert E. Sinden, Jenni M. Vuola, Angela Hunt-Cooke, Ian D. Poulton, Carolin Maier, Eveline L. Tierney, Tamara Berthoud, Sheila M. Keating, George B. Thornton, Filip Dubovsky, Daniel P. Webster, Geoffrey Butcher, Simon Correa, Adrian V. S. Hill, Sarah C. Gilbert, Rikke Fredslund Andersen, Michael Walther, Annette Schmidt, Laura Andrews, Pramod Sarpotdar, Jack Williams
Publikováno v:
Vaccine. 23(7)
ICC-1132, a recombinant virus-like particle comprising of a modified hepatitis B core protein with a B cell (NANP) and two T cell epitopes of Plasmodium falciparum circumsporozoite protein (CSP), was administered i.m. as a single 50 microg dose in Se
Autor:
Gilles Bang, Jack S. Richards, James G. Beeson, Joanne Marjason, Eveline L. Tierney, James S. McCarthy, Michelle J. Boyle, Freya J. I. Fowkes, Christopher G. Adda, Suzanne L. Elliott, Hayley Aked-Hurditch, Robin F. Anders, Paul Fahey, Pierre Druilhe, Nadia Cross, Elissa Malkin, Carole A. Long
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 9, p e24413 (2011)
PLoS ONE, Vol 6, Iss 9, p e24413 (2011)
Background: In a previous Phase 1/2b malaria vaccine trial testing the 3D7 isoform of the malaria vaccine candidate Merozoite surface protein 2 (MSP2), parasite densities in children were reduced by 62%. However, breakthrough parasitemias were dispro
Autor:
Brian R. Murphy, Eveline L. Tierney, William T. London, Anne Stokes, Frances C. Newman, Robert B. Belshe, Susan L. Hall
Publikováno v:
Virus research. 22(3)
Cold-passaged (CP) mutants derived from the JS strain of wild type wt parainfluenza type 3 virus (PIV3) are being evaluated as candidate live virus vaccines. The wt virus was serially passaged 45 times at low temperature and mutant clones with the co